Glaukos Announces Participation in the Wells Fargo Healthcare Conference

Rhea-AI Summary

Glaukos Corporation (NYSE: GKOS), a leader in ophthalmic medical technology, has announced its management will participate in the Wells Fargo Healthcare Conference on September 7, 2022, at 3:45 p.m. ET in Boston, MA. This event will highlight Glaukos' focus on novel therapies for treating glaucoma, corneal disorders, and retinal diseases. A live webcast will be available in the Investors section of the Glaukos website.

Positive

• Participation in key industry conference, potentially enhancing visibility.
• Focus on innovative therapies aligns with market demand for better glaucoma treatments.

Negative

• None.

ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 7, 2022, at 3:45 p.m. ET in Boston, MA.

A live and archived webcast for this event will be available in the Investors section of the Glaukos website at http://investors.glaukos.com.

About Glaukos

Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment paradigm, launching its first MIGS device commercially in 2012, and continues to develop a portfolio of technologically distinct and leverageable platforms to support ongoing pharmaceutical and medical device innovations. Products or product candidates for each of these platforms are designed to advance the standard of care through better treatment options across the areas of glaucoma, corneal disorders and retinal diseases.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220824005039/en/

Chris Lewis

Vice President, Investor Relations & Corporate Affairs

(949) 481-0510

clewis@glaukos.com

Source: Glaukos Corporation

FAQ

What is the date and time of Glaukos Corporation's participation in the Wells Fargo Healthcare Conference?

Glaukos Corporation will participate in the Wells Fargo Healthcare Conference on September 7, 2022, at 3:45 p.m. ET.

Where is the Wells Fargo Healthcare Conference being held?

The Wells Fargo Healthcare Conference is being held in Boston, MA.

How can I access the webcast of the Glaukos Corporation event?

The webcast for the Glaukos Corporation event will be available in the Investors section of their website.

What does Glaukos Corporation focus on in its product development?

Glaukos Corporation focuses on developing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.